Jinan Yuteng Pharmaceutical Co., Ltd.

Company Description

Jinan Yuteng Pharmaceutical Co., Ltd., located at No. 54, Qinlong Road, Pingyin County, Jinan City, Shandong Province, China, is a Sino-American joint venture specialized in chemical raw material medicines, oral solutions, medical intermediates and other series of products. In 2004, Jinan Yuteng Pharmaceutical Co., Ltd. products got GMP certificate by the State Food and Drug Administration.Our factory covers an area of 26,000 square meters, including the floor area of more than 8,000 square meters. Our company has raw material medicine production lines and advanced complete quality control centers according to the state GMP standard. The annual output of our main products, raw material medicines and oral solutions (trade name: Yi Si Qing) of isosorbide, reaches 300 tons and 2 million bottles respectively. Meanwhile, our company expands the production capacity at any time as the market demand is increasing at home and abroad. The isosorbide oral solution is one of the new categories of drugs produced by our company and is presented exclusively at home. Its technology which has filled the national gap in this aspect has achieved the internationally advanced level and won the third prize in Shandong Province Technology advancement.The distribution network has already spread across the whole country. Furthermore, the raw material medicines of isosorbide (medical grade) have won the official certificate issued by Japanese government for foreign pharmaceutical enterprises. Till now, our products have successfully come into Japanese medical market. The New Drug R & D Laboratory, co-created by our company and the Pharmaceutical College of Shandong University, lays a substantial scientific research base for the long term and stable development. With the hope of relieving the pain of disease and creating beautiful life, our company has been devoted to serving the clients with sincerity. Our company sincerely invites friends from all over the world to develop together.